These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15514251)

  • 1. Soy and mammographic breast density: plausible hypothesis but limited evidence in humans.
    Neuhouser ML
    J Nutr; 2004 Nov; 134(11):2911-2. PubMed ID: 15514251
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiologic studies of isoflavones & mammographic density.
    Maskarinec G; Verheus M; Tice JA
    Nutrients; 2010 Jan; 2(1):35-48. PubMed ID: 22253990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic breast density as a biomarker of effects of isoflavones on the female breast.
    Atkinson C; Bingham SA
    Breast Cancer Res; 2002; 4(1):1-4. PubMed ID: 11879551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic densities in a one-year isoflavone intervention.
    Maskarinec G; Williams AE; Carlin L
    Eur J Cancer Prev; 2003 Apr; 12(2):165-9. PubMed ID: 12671541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
    Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
    Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.
    Maskarinec G; Verheus M; Steinberg FM; Amato P; Cramer MK; Lewis RD; Murray MJ; Young RL; Wong WW
    J Nutr; 2009 May; 139(5):981-6. PubMed ID: 19321587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women.
    Lee E; Hsu C; Van den Berg D; Ursin G; Koh WP; Yuan JM; Stram DO; Yu MC; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):635-44. PubMed ID: 22301832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
    Speroff L
    Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
    [No Abstract]   [Full Text] [Related]  

  • 9. A 2-year soy intervention in premenopausal women does not change mammographic densities.
    Maskarinec G; Takata Y; Franke AA; Williams AE; Murphy SP
    J Nutr; 2004 Nov; 134(11):3089-94. PubMed ID: 15514280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women.
    Ursin G; Sun CL; Koh WP; Khoo KS; Gao F; Wu AH; Yu MC
    Nutr Cancer; 2006; 56(2):128-35. PubMed ID: 17474857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen, mammographic density, and breast cancer prevention.
    Boyd NF
    J Natl Cancer Inst; 2011 May; 103(9):704-5. PubMed ID: 21487099
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wolfe mammographic parenchymal patterns and breast cancer risk.
    Sickles EA
    AJR Am J Roentgenol; 2007 Feb; 188(2):301-3. PubMed ID: 17242234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of the dense breast within the French screening program: the role of ultrasonography].
    Dilhuydy MH
    J Radiol; 2008 Sep; 89(9 Pt 2):1180-6. PubMed ID: 18772802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women.
    Jakes RW; Duffy SW; Ng FC; Gao F; Ng EH; Seow A; Lee HP; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):608-13. PubMed ID: 12101107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics.
    Masala G; Assedi M; Caini S; Ermini I; Occhini D; Castaldo M; Bendinelli B; Zagni D; Tanzini D; Saieva C; Ambrogetti D; Palli D
    Tumori; 2014; 100(4):377-85. PubMed ID: 25296586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic density and breast cancer screening.
    Bell RJ
    Climacteric; 2020 Oct; 23(5):460-465. PubMed ID: 32643449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
    Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
    J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women.
    Thomson CA; Arendell LA; Bruhn RL; Maskarinec G; Lopez AM; Wright NC; Moll CE; Aickin M; Chen Z
    Menopause; 2007; 14(2):243-50. PubMed ID: 17091096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Mammographic breast density and family history of breast cancer.
    Eisinger F
    J Natl Cancer Inst; 2003 Nov; 95(22):1726; author reply 1726-7. PubMed ID: 14625266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.